PMC : Summary for Pharmerica Corporation - Yahoo Finance

U.S. Markets closed

PharMerica Corporation (PMC)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
25.30-1.45 (-5.42%)
At close: 4:02PM EST
People also watch
KNDLHCGABCMGLNPRSC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close26.75
Open26.50
Bid15.05 x 100
Ask29.40 x 100
Day's Range23.52 - 26.50
52 Week Range19.20 - 28.72
Volume625,816
Avg. Volume183,422
Market Cap778.78M
Beta0.57
PE Ratio (TTM)23.06
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journalsyesterday

    Pharmerica increases goal for merger revenue in Q4 earnings call

    Pharmerica Corp. beat analysts' estimates for fourth-quarter earnings, and CEO Greg Weishar said the company would be doubling its goal for revenue from acquisitions. The Louisville-based institutional pharmacy company said adjusted net income for the quarter rose 2.6 percent from a year earlier to $35.6 million, or 58 cents a share, from $34.7 million, or 56 cents a share last year. Weishar said in an investors call after the earnings release Friday that the company will increase its goal for revenues from acquisitions for 2017 to $200 million, up from its $100 million goal in 2016.

  • Thomson Reuters StreetEvents2 days ago

    Edited Transcript of PMC earnings conference call or presentation 24-Feb-17 3:00pm GMT

    Q4 2016 PharMerica Corp Earnings Call

  • Associated Press2 days ago

    PharMerica beats 4Q profit forecasts

    The Louisville, Kentucky-based company said it had net income of 25 cents per share. Earnings, adjusted for one-time gains and costs, came to 58 cents per share. The results beat Wall Street expectations. ...